Skip to content
Sunday, November 22, 2026
Latest
Market

Lung function falls 100ml a year in vapers aged 21 to 35, study finds

A study in Tobacco Control reported a 100ml average drop in FEV1 over 12 months among vapers aged 21 to 35, and 240ml among those vaping 30 or more times a day. A doctor called it a wake-up call.

Drying station for laboratory glassware
Drying station for laboratory glassware. Photographed 2011-01-21. File photo: Saehrimnir / Wikimedia Commons, CC BY 3.0. Image: Saehrimnir Image source · CC BY 3.0 · Display crop and size variants; source image content retained.

Key points

  • Vapers aged 21 to 35 lost an average 100ml of FEV1 over 12 months in a study reported from the journal Tobacco Control.
  • Participants vaping 30 or more times a day recorded a 240ml average drop, about 2.4 times the cohort average by VapeBrief's calculation.
  • Study authors linked sustained declines in lung function to raised COPD risk, a condition the report calls long-term and incurable.
  • Dr Mina Makaryus called the research a small pilot study and a wake-up call that vaping may not be as safe as assumed.
  • The report does not state the number of participants, device type, nicotine strength or whether a non-vaping control group was measured.
On this page
  1. The measured fall is more than double for heavy users
  2. Researchers link sustained declines to COPD risk
  3. Small sample and one-year window limit what the figures show
  4. Regulators and buyers will read the finding differently
  5. What follows the 12-month data
  6. Questions readers ask

Vapers aged 21 to 35 lost an average of 100 millilitres of forced expiratory volume in one second (FEV1) over 12 months, according to a study in the journal Tobacco Control described in a UNILAD report.

Participants who vaped 30 or more times a day recorded a 240-millilitre drop, against 100 millilitres for the group as a whole. FEV1 measures how much air a person can force out of the lungs in one second.

The measured fall is more than double for heavy users

VapeBrief’s calculation: dividing the 240ml figure by the 100ml average gives 2.4, so the heaviest-use group lost about 2.4 times the cohort average over the same 12 months. Both numbers come from the same reported cohort, so they compare heavy users with the whole group, not with a non-vaping control.

Group Average FEV1 change over 12 months (ml)
All participants aged 21 to 35 100
Participants vaping 30+ times a day 240

The study authors warned that continued falls in lung function could raise the risk of developing chronic obstructive pulmonary disease, a long-term condition the report describes as incurable. The reported findings cover a 12-month period only.

Dr Mina Makaryus, speaking to the New York Post, said the change was statistically significant within that year and that longer follow-up would probably show further decline. He also said patients who vape are often already living with asthma or obstructive lung disease, based on his own practice.

Makaryus described the research as a small pilot study and called on vapers to treat it as a warning that vaping may not be as safe as assumed.

Small sample and one-year window limit what the figures show

The report does not give the number of participants, their location, the device type, the nicotine strength or the e-liquid composition used. It also does not say whether a non-vaping comparison group was measured. Without those details, the 100ml and 240ml figures describe change within the vaping group only, not a difference against people who do not vape.

Earlier research has reached related conclusions by other routes. A 2019 study by researchers at the University Medical Center Mainz and Harvard reported that a single e-cigarette session raised heart rate and stiffened arteries in 20 healthy smokers, and that endothelial function was impaired. That work did not measure FEV1 and does not corroborate the lung-function numbers above.

Regulators and buyers will read the finding differently

For regulators, the reported association between heavy daily use and a steeper FEV1 fall adds to the case for collecting device and e-liquid data alongside health outcomes, since the report does not identify what participants inhaled. Health agencies that cite this study should pair it with the sample size, which the report omits.

For manufacturers, exporters and distributors in the Shenzhen supply chain, the practical effect is analytical: product dossiers and post-market surveillance submissions that report puff counts or daily-use proxies face closer questions when a study ties high-frequency use to larger measured declines. VapeBrief’s analysis is that brands selling high-puff-count or high-frequency-use formats have the most exposure to scrutiny, while the absence of device detail in the study limits how far any specific product can be linked to the figures.

What follows the 12-month data

Makaryus said longer studies would be needed to test whether the decline continues, and encouraged vapers to discuss nicotine alternatives with their doctor. The reported 12-month results remain the only quantitative outcome in the source material; no follow-up period, publication date for a fuller dataset or regulatory response is stated.

Questions readers ask

What did the study measure?

Researchers measured FEV1, the volume of air a person can force out of the lungs in one second, in vapers aged 21 to 35 over 12 months, according to the report.

How large was the drop for heavy users?

Participants who vaped 30 or more times a day saw FEV1 fall by 240 millilitres on average, against 100 millilitres for the group overall.

Share

Sources

18+ only. This site is for adult readers and provides news and information only. It is not medical, legal or purchase advice. Nicotine is addictive. Always check the official text of any regulation in your market. Health Information

Dylan Harper

Dylan Harper covers the vape industry and market trends for VapeBrief. He previously spent seven years in consumer-goods market research.

About this byline →

Daily Brief newsletter

A concise email at 08:00 U.S. Eastern time each day, with links to the previous day’s published briefs.

Topics of interest

Active immediately, no confirmation click needed. Every email includes an unsubscribe link. See our Privacy Policy.